Evidence map›Paper›PMID 37170496›Full record

ArticleBiophysical journal2023

Distinct growth regimes of α-synuclein amyloid elongation.

Istvan Horvath, Hannah Welte, Jeremy D Schmit, Michael Kovermann, Pernilla Wittung-Stafshede

Open access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Istvan HorvathDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Hannah WelteDepartment of Chemistry, University of Konstanz, Konstanz, Germany.
Jeremy D SchmitDepartment of Physics, Kansas State University, Manhattan, Kansas. Electronic address: schmit@phys.ksu.edu.
Michael KovermannDepartment of Chemistry, University of Konstanz, Konstanz, Germany. Electronic address: michael.kovermann@uni-konstanz.de.
Pernilla Wittung-StafshedeDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden. Electronic address: pernilla.wittung@chalmers.se.
Chalmers University of Technology · SEUniversity of Konstanz · DEKansas State University · US

Funding

Structure-function properties in liquid organellesR01GM141235 · NIGMS · KANSAS STATE UNIVERSITY · PI SCHMIT, JEREMY DAVID · 2021 to 2024
$1.3M
NIGMS NIH HHS R01 GM141235
6 · The paper itself

Abstract

Addition of amyloid seeds to aggregation-prone monomers allows for amyloid fiber growth (elongation) omitting slow nucleation. We here combine Thioflavin T fluorescence (probing formation of amyloids) and solution-state NMR spectroscopy (probing disappearance of monomers) to assess elongation kinetics of the amyloidogenic protein, α-synuclein, for which aggregation is linked to Parkinson's disease. We found that both spectroscopic detection methods give similar kinetic results, which can be fitted by applying double exponential decay functions. When the origin of the two-phase behavior was analyzed by mathematical modeling, parallel paths as well as stop-and-go behavior were excluded as possible explanations. Instead, supported by previous theory, the experimental elongation data reveal distinct kinetic regimes that depend on instantaneous monomer concentration. At low monomer concentrations (toward end of experiments), amyloid growth is limited by conformational changes resulting in β-strand alignments. At the higher monomer concentrations (initial time points of experiments), growth occurs rapidly by incorporating monomers that have not successfully completed the conformational search. The presence of a fast disordered elongation regime at high monomer concentrations agrees with coarse-grained simulations and theory but has not been detected experimentally before. Our results may be related to the wide range of amyloid folds observed.

Indexed as

alpha-SynucleinAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsFluorescenceKineticsMolecular Conformationalpha-SynucleinAmyloidAmyloid beta-PeptidesAmyloidogenic Proteins

Identifiers

PMID37170496
PMCPMC10323017
OpenAlexW4376226408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.